To the Editor: I read with interest the article by Medi and colleagues,1 but note that the authors do not mention the effect of supraventricular tachycardia on atrial natriuretic peptide — a hormone that causes vasodilation and renal excretion of sodium and water. Plasma levels of atrial natriuretic peptide increase markedly during supraventricular tachycardia.2 Pacing studies reveal that release of atrial natriuretic peptide occurs when the heart rate is greater than 120 beats/min.3 The resultant diuresis would lead to an urge to urinate and, in a prolonged episode of tachycardia, to polyuria.4,5
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- Research Affairs, Chulalongkorn University, Faculty of Medicine, Bangkok, Thailand.
Correspondence: weekitti@gmail.com
- 1. Medi C, Kalman JM, Freedman SB. Supraventricular tachycardia. Med J Aust 2009; 190: 255-260.
- 2. Kojima S, Fujii T, Ohe T, et al. Physiologic changes during supraventricular tachycardia and release of atrial natriuretic peptide. Am J Cardiol 1988; 62: 576-579.
- 3. Vesely DL. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res 2001; 51: 647-658.
- 4. Fox DJ, Tischenko A, Krahn AD, et al. Supraventricular tachycardia: diagnosis and management. Mayo Clin Proc 2008; 83: 1400-1411.
- 5. Delacrétaz E. Supraventricular tachycardia. N Engl J Med 2006; 354: 1039-1051.
Online responses are no longer available. Please refer to our instructions for authors page for more information.